Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:18 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
NCT00181220 · Johns Hopkins University · PHASE1 · withdrawn · last registry update 2020-05-18 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “PI left JHU and is not able to be reached for updates” | – | Registry record, Johns Hopkins University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ALDH5A1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-04-01Results posted on the registry: New York State Psychiatric Institute, Fluoxetine + Citalopram (NCT02473250)
- 2021-02-09Also stopped (terminated): Meyer Children's Hospital IRCCS, Doxorubicin (NCT02758366)
- 2021-01-07Phase 3 first posted: Universidad Autonoma de San Luis Potosí, Valproate Sodium + Memantine (NCT04698525)
- 2020-10-20Results posted on the registry: Children's Hospital Medical Center, Cincinnati, Risperidone oral solution + Valproate Oral Solution (NCT00221403)
- 2020-10-14Results posted on the registry: Children's Hospital Medical Center, Cincinnati, Ethosuximide + Lamotrigine (NCT00088452)
- 2020-09-02Results posted on the registry: Federal University of Rio Grande do Sul, Lithium + Valproic Acid (NCT02870283)
- 2020-08-14Results posted on the registry: The University of Texas Health Science Center at San Antonio, Lithium + Divalproex (NCT01588457)
- 2020-06-11Results posted on the registry: University of South Florida, quetiapine SR + divalproex sodium ER (NCT00579280)
- 2020-03-27Results posted on the registry: Food and Drug Administration (FDA), Oxcarbazepine (brand name vs generic drugs) + Divalproex Sodium (brand name vs generic drugs) (NCT02707965)
- 2020-02-28Results posted on the registry: University of Virginia, Fosphenytoin + Levetiracetam (NCT01960075)
- 2020-02-25Results posted on the registry: M.D. Anderson Cancer Center, Placebo + Valproic Acid (VPA) (NCT01900730)
- 2020-02-25Also stopped (terminated): M.D. Anderson Cancer Center, Placebo + Valproic Acid (VPA) (NCT01900730)
- 2020-02-18Phase 3 first posted: Johns Hopkins University, Absence epilepsy medications (NCT04274179)
- 2020-02-10Results posted on the registry: Washington University School of Medicine, Valproate + Placebo (NCT00167934)
- 2019-10-21Also stopped (terminated): OPKO Health, Inc., ELND005 + Lamotrigine (NCT01674010)
- 2019-10-09Results posted on the registry: Gregory Jicha, 323-5550, Valproic Acid + Placebo (NCT01729598)
- 2019-09-16Results posted on the registry: Organon and Co, Asenapine + Placebo (NCT00145470)
- 2019-09-11Results posted on the registry: University of California, San Diego, divalproex ER + quetiapine (NCT00397020)
- 2019-07-29Phase 3 first posted: National Cheng-Kung University Hospital, Memantine or placebo (NCT04035798)
- 2019-07-17Results posted on the registry: University Hospitals Cleveland Medical Center, Divalproex Sodium ER + Placebo (NCT00194116)
- 2019-06-26Results posted on the registry: Stanford University, Valproic Acid + Placebo (NCT02343575)
- 2019-06-26Also stopped (terminated): Stanford University, Valproic Acid + Placebo (NCT02343575)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision